Superficial Vein Thrombosis
Which one of the following statements regarding the use of anticoagulants for the treatment of superficial vein thrombosis (SuVT) is false?
- Systemic anticoagulation with fondaparinux for 45 days is typically considered for patients with SuVT greater than 5 cm in length and greater than 3 cm away from the deep vein junction.
- Conservative treatments include topical NSAID creams.
- If the SuVT is closer than 3 cm to the deep vein junctions, therapeutic anticoagulation with regimens similar to those used for management of deep vein thrombosis should be considered.
- People with SuVT are not at increased risk of subsequent deep vein thrombosis.